Facultad de Farmacia y Nutrición (FFN)
Centro académico
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublications in collaboration with researchers from Ludwig Maximilian University of Munich (5)
2019
-
Nanobiotechnology in parkinson’s disease
Nanobiotechnology in Neurodegenerative Diseases (Springer International Publishing), pp. 177-208
2018
-
Novel PAMAM-PEG-peptide conjugates for siRNA delivery targeted to the transferrin and epidermal growth factor receptors
Journal of Personalized Medicine, Vol. 8, Núm. 1
2015
-
Evaluation of improved PAMAM-G5 conjugates for gene delivery targeted to the transferrin receptor
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 116-122
-
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
Nature Communications, Vol. 6
2010
-
Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery
Journal of Controlled Release, Vol. 146, Núm. 1, pp. 99-105